Podcast Episodes

Back to Search
HER2+ Endometrial and Ovarian Cancers: Targeted Therapy Highlights From ESMO 2025

Episode 608

Drs. Dizon and Campos discuss how new antibody drug conjugates like trastuzumab deruxtecan are transforming treatment options for HER2+ gynecological…

7 months, 3 weeks ago

Short Long
View Episode
HER2+ Endometrial and Ovarian Cancers: Targeted Therapy Highlights From ESMO 2025

Episode 608

Drs. Dizon and Campos discuss how new antibody drug conjugates like trastuzumab deruxtecan are transforming treatment options for HER2+ gynecological…

7 months, 3 weeks ago

Short Long
View Episode
HER2+ Endometrial and Ovarian Cancers

Episode 607

Drs. Campos and Dizon explore how groundbreaking research is redefining HER2-targeted therapies in gynecological cancers, moving beyond the old one-s…

7 months, 3 weeks ago

Short Long
View Episode
HER2+ Endometrial and Ovarian Cancers

Episode 607

Drs. Campos and Dizon explore how groundbreaking research is redefining HER2-targeted therapies in gynecological cancers, moving beyond the old one-s…

7 months, 3 weeks ago

Short Long
View Episode
Can an oral PCSK9 inhibitor finally close the LDL gap for high-risk patients?

Episode 606

A phase 3 trial in The New England Journal of Medicine found that the oral PCSK9 inhibitor enlicitide reduced LDL by 57% at 24 weeks in high-risk pat…

7 months, 4 weeks ago

Short Long
View Episode
Can an oral PCSK9 inhibitor finally close the LDL gap for high-risk patients?

Episode 606

A phase 3 trial in The New England Journal of Medicine found that the oral PCSK9 inhibitor enlicitide reduced LDL by 57% at 24 weeks in high-risk pat…

7 months, 4 weeks ago

Short Long
View Episode
Retinal Disease Updates from AAO 2025

Episode 605

Drs. Danzig and Vakharia review new AAO 2025 data on high-dose aflibercept, early corticosteroid implants, and emerging TKI inserts for RVO, DME, and…

8 months, 1 week ago

Short Long
View Episode
Retinal Disease Updates from AAO 2025

Episode 605

Drs. Danzig and Vakharia review new AAO 2025 data on high-dose aflibercept, early corticosteroid implants, and emerging TKI inserts for RVO, DME, and…

8 months, 1 week ago

Short Long
View Episode
Are UTIs being over treated via telehealth—and who actually needs antibiotics?

Episode 604

A JAMA Network Open consensus guide standardizes adult UTI triage for telehealth and in-person care. Nonpregnant women with classic cystitis symptoms…

8 months, 1 week ago

Short Long
View Episode
Are UTIs being over treated via telehealth—and who actually needs antibiotics?

Episode 604

A JAMA Network Open consensus guide standardizes adult UTI triage for telehealth and in-person care. Nonpregnant women with classic cystitis symptoms…

8 months, 1 week ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us